Regulation of vascular angiotensin II receptors by EGF

American Journal of Physiology - Cell Physiology

Volumn 273, Issue 4 42-4, 1997, Pages

  Ullian, Michael E ^a,b   Raymond, John R ^a   Willingham, Mark C ^a   Paul, Richard V ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

G proteins; Mitogen activated protein kinase; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CELL SURFACE RECEPTOR; CORTICOSTERONE; EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; RADIOLIGAND; TYRPHOSTIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM INJURY; HYPERTROPHY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0030662534     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1997.273.4.c1241     Document Type: Article

References (26)

1. Bagby, S. P., E. A. Kirk, L. H. Mitchell, M. M. O'Reilly, W. E. Holden, P. E. Stenberg, and A. C. Bakke. Proliferative synergy of ANG II and EGF in porcine aortic vascular smooth muscle cells. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F239-F249, 1993.
2. Crowley, S. T., C. J. Ray, D. Nawaz, R. A. Majack, and L. D. Horwitz. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1641-H1647, 1995.
3. Gan, B. S., and M. D. Hollenberg. Autoradiographic localization of binding sites for epidermal growth factor-urogastrone in coronary arteries. Eur. J. Pharmacol. 167:407-410, 1989.
4. Gazit, A., P. Yaish, C. Gilon, and A. Levitski. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:2344-2352, 1989.
5. Grosenbaugh, D. A., M. S. Amoss, D. M. Hood, S. J. Morgan, and J. D. Williams. Epidermal growth factor-mediated effects on equine vascular smooth muscle cells. Am. J. Physiol. 255 (Cell Physiol. 24): C447-C451, 1988.
6. Guo, D. F., and T. Inagami. Epidermal growth factor-enhanced human angiotensin II type 1 receptor. Hypertension 23: 1032-1035, 1994.
7. Hart, M. J., P. G. Polakis, T. Evans, and R. A. Cerione. The identification and characterization of an epidermal growth factor-stimulated phosphorylation of a specific low molecular weight GTP-binding protein in a reconstituted phospholipid vesicle system. J. Biol. Chem. 265:5990-6001, 1990.
8. Hayry, P., M. Myllarniemi, E. Aavik, S. Alatalo, P. Aho, S. Yilmaz, A. Raisanen-Sokolowski, G. Cozzone, B. A. Jameson, and R. Baserga. Stabile D-peptide analog of insulinlike growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9: 13361344, 1995.
9. Hsu, C. J., D. R. Hurwitz, M. Mervic, and A. Zilberstein. Autophosphorylation of the intracellular domain of the epider-mal growth factor receptor results in different effects on its tyrosine kinase activity with various peptide substrates. J. Biol. Chem. 266:603-608, 1991.
10. Klemke, R. L., M. Yebra, E. M. Bayna, and D. A. Cheresh. Receptor tyrosine kinase signaling required for integral avß5-directed cell motility but not adhesion on vitronectin. J. Cell Biol. 127:859-866, 1994.
11. Liang, M., and J. C. Garrison. Epidermal growth factor activates phospholipase C in rat hepatocytes via a difierent mechanism from that in A431 or rat 1hER cells. Mol. Pharmacol. 42: 743-752, 1992.
12. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275, 1951.
13. Margolis, B., S. G. Rhee, S. Felder, M. Mervic, R. Lyall, A. Levitzki, A. Ullrich, and A. Zilberstein. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57:1101-1107, 1989.
14. Miyagawa, J., S. Higashiyama, S. Kawata, I. Yoshiaki, S. Tamura, K. Yamamoto, M. Nishida, T. Nakamura, S. Yamashita, Y. Matsuzawa, and N. Taniguchi. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95:404-411, 1995.
15. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Bernstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236, 1991.
16. Nickenig, G., and T. J. Murphy. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol. Pharmacol. 46:653-659, 1994.
17. Osterrieder, W., R. K. M. Muller, J. S. Powell, J. P. Clozel, F. Hefti, and H. R. Baumgartner. Role of angiotensin II in injury-induced neointimal formation in rats. Hypertension 18, Suppl. II: II-60-II-64, 1991.
18. Schiffrin, E. L., D. J. Franks, and J. Gutkowska. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can. J. Physiol. Pharmacol. 63:1522-1527, 1985.
19. Temizer, D. H., M. Yoshizumi, M. A. Perrella, E. E. Susanni, T. Quertermous, and M. E. Lee. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267: 24892-24896, 1992.
20. Ullian, M. E., and J. J. Fine. Mechanisms of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J. Cell. Physiol. 161:201-208, 1994.
21. Ullian, M. E., F. N. Hutchison, D. J. Hazen-Martin, and T. A. Morinelli. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1525-C1531, 1993.
22. Ullian, M. D., and S. L. Linas. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J. Clin. Invest. 84:840-846, 1989.
23. Ullian, M. E., and S. L. Linas. Angiotensin II surface receptor coupling to inositol trisphosphate formation in vascular smooth muscle cells. J. Biol. Chem. 265:195-200, 1990.
24. Ullian, M. E., J. R. Schelling, and S. L. Linas. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 20:67-73, 1992.
25. Ullian, M. E., L. G. Walsh, and T. A. Morinelli. Potentiation of angiotensin II action by corticosteroids in vascular tissue. Cardiovasc. Res. 32:266-273, 1996.
26. Yaish, P., A. Gazit, C. Gilon, and A. Levitzki. Blocking of EGF-dependent cell proliferation by EGF-receptor kinase inhibitors. Science 242:933-935, 1988.